Metropolitan Life Insurance CO Harvard Bioscience Inc Transaction History

Metropolitan Life Insurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.02 - $5.39 $731 - $980	182 Added 8.45%	2,337 $9,000
Q2 2023 Aug 10, 2023	BUY	$4.19 - $6.16 $9,029 - $13,274	2,155 New	2,155 $11,000
Q2 2022 Aug 11, 2022	SELL	$3.28 - $6.42 $9,072 - $17,757	-2,766 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$5.16 - $7.14 $14,272 - $19,749	2,766 New	2,766 $17,000
Q1 2022 Mar 30, 2023	SELL	$5.16 - $7.14 $44,520 - $61,603	-8,628 Reduced 75.72%	2,766 $17,000
Q1 2022 May 12, 2022	SELL	$5.16 - $7.14 $44,520 - $61,603	-8,628 Reduced 75.72%	2,766 $17,000
Q4 2021 Jun 21, 2023	BUY	$6.37 - $8.18 $72,579 - $93,202	11,394 New	11,394 $80,000
Q4 2021 Mar 30, 2023	BUY	$6.37 - $8.18 $1,133 - $1,456	178 Added 1.59%	11,394 $80,000
Q4 2021 Feb 15, 2022	BUY	$6.37 - $8.18 $1,133 - $1,456	178 Added 1.59%	11,394 $80,000
Q3 2021 Jun 21, 2023	BUY	$6.98 - $8.47 $78,287 - $94,999	11,216 New	11,216 $78,000
Q3 2021 Mar 30, 2023	BUY	$6.98 - $8.47 $78,287 - $94,999	11,216 New	11,216 $78,000
Q3 2021 Nov 15, 2021	BUY	$6.98 - $8.47 $78,287 - $94,999	11,216 New	11,216 $78,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.